A head-mounted iPhone-based ophthalmoscope is the latest step in the rapidly evolving world of smartphone fundoscopy

In August, The Ophthalmologist will publish a special issue showcasing the very best images from the field of ophthalmology.

Valeant and Allergan continue to joust, Santen purchases MSD’s ophthalmology drug portfolio in selected markets, and Kala completes a US$22.5 million Series B financing round

Purchase of the ex-US rights for Fovista is costing Novartis US$200 million down and up to a cool US$1 billion in milestone payments

Common yoga positions significantly raise IOP for prolonged periods

The body’s own regulatory T-lymphocytes, known as Tregs, can be taught to douse inflammation.

The visual cortex processes auditory information – both real and imaginary

At last, a unique and useful function for femtosecond laser systems has emerged.

What does analysis of the last five years of the literature on Stargardt Disease tell us about the priorities of the field and the major contributors to it?

The concept of using photoactivated chromophores for corneal cross-linking (PACK-CXL) as a weapon against infectious keratitis is compelling. The evidence suggests that PACK-CXL could have a dramatic impact on a major cause of global blindness… but only if the expensive, bulky technology (and the requirement for a corneal surgeon in a sterile operating theater) can be overcome. One company may have the answer.